X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3120) 3120
Publication (333) 333
Book Review (31) 31
Book Chapter (7) 7
Conference Proceeding (6) 6
Dissertation (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2609) 2609
index medicus (1883) 1883
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1604) 1604
male (1504) 1504
statins (1497) 1497
female (1319) 1319
middle aged (1034) 1034
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (855) 855
aged (809) 809
cholesterol (807) 807
animals (803) 803
adult (612) 612
risk factors (550) 550
simvastatin (527) 527
immunology (496) 496
atorvastatin (490) 490
cardiac & cardiovascular systems (479) 479
cardiovascular disease (478) 478
atherosclerosis (468) 468
lipids (447) 447
inflammation (437) 437
drug therapy (421) 421
treatment outcome (416) 416
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (402) 402
abridged index medicus (384) 384
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (369) 369
medicine (363) 363
mortality (363) 363
research article (356) 356
multidisciplinary sciences (355) 355
risk (354) 354
therapy (351) 351
mice (349) 349
analysis (345) 345
internal medicine (339) 339
atorvastatin calcium (328) 328
research (314) 314
science (312) 312
pravastatin (300) 300
cardiovascular diseases (297) 297
prevention (292) 292
disease (287) 287
medicine, general & internal (281) 281
care and treatment (280) 280
pharmacology & pharmacy (266) 266
c-reactive protein (262) 262
heart attacks (245) 245
diabetes (244) 244
patients (240) 240
health aspects (238) 238
cholesterol, ldl - blood (237) 237
statin (233) 233
cardiovascular agents (228) 228
enzymes (228) 228
studies (228) 228
cardiovascular (227) 227
antilipemic agents (224) 224
cardiology (222) 222
coronary-heart-disease (215) 215
simvastatin - pharmacology (215) 215
aged, 80 and over (212) 212
expression (210) 210
rats (209) 209
hypercholesterolemia (207) 207
proteins (202) 202
transplantation (202) 202
low density lipoproteins (200) 200
retrospective studies (200) 200
cell biology (196) 196
cardiology and cardiovascular medicine (190) 190
hypercholesterolemia - drug therapy (189) 189
cardiovascular diseases - prevention & control (188) 188
cells, cultured (186) 186
clinical trials (184) 184
cholesterol - blood (183) 183
time factors (181) 181
dose-response relationship, drug (179) 179
myocardial-infarction (179) 179
medical research (178) 178
drugs (176) 176
lipoproteins (173) 173
surgery (173) 173
cardiovascular-disease (171) 171
peripheral vascular disease (170) 170
heptanoic acids - therapeutic use (169) 169
pyrroles - therapeutic use (169) 169
coa reductase inhibitors (166) 166
drug therapy, combination (166) 166
article (165) 165
biomarkers - blood (161) 161
follow-up studies (161) 161
rodents (161) 161
pharmacology (159) 159
prospective studies (158) 158
rosuvastatin (158) 158
low density lipoprotein (157) 157
coronary heart disease (155) 155
dosage and administration (154) 154
anticholesteremic agents - therapeutic use (153) 153
hmg-coa reductase (153) 153
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3071) 3071
Japanese (11) 11
German (10) 10
French (8) 8
Russian (7) 7
Chinese (3) 3
Italian (3) 3
Polish (3) 3
Spanish (2) 2
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature communications, ISSN 2041-1723, 08/2019, Volume 10, Issue 1, pp. 3492 - 13
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, pp. 3210 - 3227
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, pp. 3168 - 3209
Journal Article
International Journal of Clinical Pharmacy, ISSN 2210-7703, 6/2019, Volume 41, Issue 3, pp. 719 - 727
Background Older persons living alone have been associated with poorer health outcomes and higher mortality rate. However, little is known about the drug... 
Medication adherence | Singapore | Medicine & Public Health | Pharmacy | Community-dwelling | Drug-related problems | Internal Medicine | Living alone | Elderly | Geriatrics | Hydroxymethylglutaryl-CoA reductase | Chronic conditions | Housing | HMG-CoA reductase inhibitors | Statins
Journal Article
Journal Article
Inflammation, ISSN 0360-3997, 4/2019, Volume 42, Issue 2, pp. 407 - 411
Journal Article
Current Diabetes Reviews, ISSN 1573-3998, 01/2019, Volume 15, Issue 3, pp. 213 - 223
Journal Article
Evidence-based Complementary and Alternative Medicine, ISSN 1741-427X, 2019, Volume 2019, pp. 3269047 - 10
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2018, Volume 25, Issue 42, pp. 5835 - 5846
Adverse drug reactions (ADRs) represent an important cause of morbidity and mortality worldwide. Statins are a class of drugs whose main adverse effects are... 
Liver damage | Single nucleotide polymorphisms (SNPs) | HCV | MetS | Genetic susceptibility | Statins | METABOLIC SYNDROME | CHEMISTRY, MEDICINAL | MYOCARDIAL-INFARCTION | CAUSE-SPECIFIC MORTALITY | COMBINATION THERAPY | BIOCHEMISTRY & MOLECULAR BIOLOGY | AUTOIMMUNE HEPATITIS | NONALCOHOLIC FATTY LIVER | HEPATOCELLULAR-CARCINOMA | HEPATITIS-C VIRUS | single nucleotide polymorphisms (SNPs) | PHARMACOLOGY & PHARMACY | genetic susceptibility | CORONARY-HEART-DISEASE | LOWERING TREATMENT | liver damage | Cardiovascular Diseases - etiology | Genetic Predisposition to Disease | Cardiovascular Diseases - drug therapy | Humans | Chemical and Drug Induced Liver Injury - genetics | HLA Antigens - genetics | Cardiovascular Diseases - pathology | Organic Anion Transporters - genetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | ATP-Binding Cassette Transporters - genetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cytochrome P-450 Enzyme System - genetics | Hepatitis C - complications | Hepatitis C - pathology | Chemical and Drug Induced Liver Injury - etiology | Cytochrome | Liver | Medical treatment | Cytochrome P450 | Genomes | Pharmacology | Patients | Morbidity | Organic anion transporting polypeptide | Side effects | Genetic factors | Cardiovascular diseases | Hepatotoxicity | Transporter | Metabolic disorders | Myopathy | Cytochromes P450
Journal Article
Journal of the Science of Food and Agriculture, ISSN 0022-5142, 01/2019, Volume 99, Issue 2, pp. 576 - 586
BACKGROUND The lack of estrogen in postmenopausal women is a key risk factor for disorders of lipid metabolism and for obesity. Except in cases where estrogen... 
ovariectomized rats | hypolipidemic effects | Chickpea peptides (ChPs) | estrogen receptor | Val‐Phe‐Val‐Arg‐Asn | Val-Phe-Val-Arg-Asn | CHOLESTEROL | FOOD SCIENCE & TECHNOLOGY | ANTIOXIDANT PEPTIDES | IDENTIFICATION | CHICKPEAS | HYDROLYSATE | INSULIN | ENERGY HOMEOSTASIS | PATHWAY | AGRICULTURE, MULTIDISCIPLINARY | FATTY LIVER | CHEMISTRY, APPLIED | MODULATION | Hyperlipidemias - genetics | Receptors, Estrogen - metabolism | Humans | Diet, High-Fat - adverse effects | Cicer - chemistry | Peptides - administration & dosage | Adipose Tissue - metabolism | Hydroxymethylglutaryl CoA Reductases - metabolism | Liver - drug effects | Menopause - drug effects | Female | Sterol Regulatory Element Binding Protein 1 - metabolism | Receptors, Estrogen - genetics | Hyperlipidemias - metabolism | Ovariectomy | Hyperlipidemias - drug therapy | Liver - metabolism | Rats | Rats, Sprague-Dawley | Hep G2 Cells | Triglycerides - metabolism | Animals | Menopause - metabolism | Sterol Regulatory Element Binding Protein 1 - genetics | Hypolipidemic Agents - administration & dosage | Lipid Metabolism - drug effects | Cholesterol, LDL - metabolism | Adipose Tissue - drug effects | Hydroxymethylglutaryl CoA Reductases - genetics | Lipoproteins (low density) | Adipose tissue | Peptides | Liver | Estrogens | Body weight | Menopause | Disorders | Estrogen receptors | Lipids | Biosynthesis | Chickpeas | Density | Risk factors | Proteins | Receptors | Estrogen replacement therapy | Sterol regulatory element-binding protein | Lipid metabolism | Lipoproteins (high density) | Obesity | Bile acids | Liver X receptors | Hyperlipidemia | Metabolism | Risk analysis | Fatty acids | Cholesterol | Post-menopause | Organic chemistry | Body size | Hormone replacement therapy | Peroxisome proliferator-activated receptors | Bile | Reductase | Index Medicus
Journal Article
PLOS ONE, ISSN 1932-6203, 12/2018, Volume 13, Issue 12, p. e0207194
Journal Article